These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6260135)

  • 21. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular variants of the lipoproteins.
    Galton DJ; Stocks J; Rees A
    Clin Sci (Lond); 1983 Jun; 64(6):559-63. PubMed ID: 6404583
    [No Abstract]   [Full Text] [Related]  

  • 23. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 24. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of the apolipoprotein-E isoprotein system in man.
    Cumming AM; Robertson FW
    J Med Genet; 1982 Dec; 19(6):417-23. PubMed ID: 7154039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The carbohydrate content of apolipoprotein E from human very low density lipoproteins.
    Jain RS; Quarfordt SH
    Life Sci; 1979 Oct; 25(15):1315-23. PubMed ID: 92742
    [No Abstract]   [Full Text] [Related]  

  • 27. A method to screen apolipoprotein polymorphisms in whole plasma: description of apolipoprotein A-IV variants in dyslipidemias and a reassessment of apolipoprotein A-I in Tangier disease.
    Bisgaier CL; Lee ES; Glickman RM
    Biochim Biophys Acta; 1987 Apr; 918(3):242-9. PubMed ID: 3105587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restriction enzyme analysis of the apolipoprotein A-I gene in fish eye disease and Tangier disease.
    Rees A; Stocks J; Schoulders C; Carlson LA; Baralle FE; Galton DJ
    Acta Med Scand; 1984; 215(3):235-7. PubMed ID: 6428166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High-resolution method for the analysis of apo(a) isoforms].
    Yanagi H
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():837-44. PubMed ID: 11351701
    [No Abstract]   [Full Text] [Related]  

  • 31. Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.
    Mann WA; Gregg RE; Sprecher DL; Brewer HB
    Biochim Biophys Acta; 1989 Oct; 1005(3):239-44. PubMed ID: 2804053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial study on the "double pre-beta lipoproteinemia" and on a polymorphic pattern of apolipoprotein E (EIV "variant" pattern) from human very low density lipoproteins (VLDL).
    Pagnan A; Zanetti G; Guarini P
    Atherosclerosis; 1980 Apr; 35(4):351-61. PubMed ID: 7378117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein polymorphism and multifactorial hyperlipidaemia.
    Utermann G
    J Inherit Metab Dis; 1988; 11 Suppl 1():74-86. PubMed ID: 3141688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual familial lipoprotein C-III associated with apolipoprotein C-III-O preponderance.
    Maeda H; Uzawa H; Kamei R
    Biochim Biophys Acta; 1981 Sep; 665(3):578-85. PubMed ID: 7295752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the apolipoproteins of rat plasma lipoproteins.
    Swaney JB; Braithwaite F; Eder HA
    Biochemistry; 1977 Jan; 16(2):271-8. PubMed ID: 65178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III.
    Utermann G; Vogelberg KH; Steinmetz A; Schoenborn W; Pruin N; Jaeschke M; Hees M; Canzler H
    Clin Genet; 1979 Jan; 15(1):37-62. PubMed ID: 215360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia.
    von Eckardstein A; Holz H; Sandkamp M; Weng W; Funke H; Assmann G
    J Clin Invest; 1991 May; 87(5):1724-31. PubMed ID: 2022742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic fate of VLDL apolipoproteins B and E in hepatectomized rats.
    Davis RA; Hartman AD; Dory L; Van Lenten BJ; Roheim PS
    Biochim Biophys Acta; 1981 Jul; 665(1):154-64. PubMed ID: 7284413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamic behavior of apoproteins of human plasma very low density lipoproteins and lipolysis regulation].
    Dergunov AD; Shuvaev VV; Perova NV
    Biokhimiia; 1990 Jan; 55(1):134-46. PubMed ID: 2160840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein-E degradation in human very low density lipoproteins by plasma protease(s): chemical and biological consequences.
    Bradley WA; Gilliam EB; Gotto AM; Gianturco SH
    Biochem Biophys Res Commun; 1982 Dec; 109(4):1360-7. PubMed ID: 6301435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.